Glioblastoma (GBM) continues to be the most common and malignant primary brain tumor in adults carrying a dismal prognosis with less than 15 months median survival. This Conference intends to promote clinical and basic research on this devastating disease.

Go to registration

Registration

To participate in this conference, please follow the link.

background

II International Symposium on Clinical and Basic Investigation in Glioblastoma-GBM2015' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

The EACCME is an institution of the European Union of Medical Specialists (UEMS), http://www.uems.net.

The ‘II International Symposium on Clinical and Basic Investigation in Glioblastoma-GBM2015’ is designated for a maximum of (or ‘for up to’) 15 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

 Organized by